15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering Dentsply Sirona Inc, 3 rate it Buy or better, 9 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets span $9.00 to $17.00, a moderate spread. The average target of $13.92 sits 3% above the current $13.50. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.37 next quarter toward $1.55 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Hold
Strong Buy00%
Buy321%
Hold964%
Sell214%
Strong Sell00%
Based on 14 analysts giving stock ratings to Dentsply Sirona Inc.
As of Jul, 3 of 14 firms rate XRAY a Buy (9 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
XRAY EPS & revenue forecast
EPS · NEXT QUARTER
$0.37
Range $0.34 – $0.42 · 18 analysts · +0% YoY
Next period, 18 analysts expect Dentsply Sirona Inc to earn $0.37 a share (range $0.34 – $0.42), versus $0.37 a year earlier. Full-year consensus is $1.42, growing to $1.55 the year after.
REVENUE · NEXT QUARTER
$874.2M
Range $857.7M – $894.8M · 18 analysts · -3% YoY
Revenue is expected to reach $874.2M (range $857.7M – $894.8M), -3.3% year-over-year. Full-year consensus is $3.6B, rising to $3.7B next year.
Top analysts covering Dentsply Sirona Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XRAY.
#1
Jonathan Block
Stifel · Rank #172
Hold
$14.00+3.7% to target
Overall win rate
42%
+ Follow
#2
David Saxon
Needham · Rank #264
Hold
No targeton XRAY
Overall win rate
34%
+ Follow
#3
Jason Bednar
Piper Sandler · Rank #303
Hold
$13.00-3.7% to target
Overall win rate
33%
+ Follow
#4
Michael Petusky
Barrington Research · Rank #322
Buy
$17.00+25.9% to target
Overall win rate
29%
+ Follow
#5
Kevin Caliendo
UBS
Buy
$17.00+25.9% to target
Coverage
—
+ Follow
XRAY stock forecast FAQ
What is XRAY's average 12-month price target?+
The 11 analysts with a live target average $13.92 for Dentsply Sirona Inc over the next 12 months, ranging from a $17.00 high to a $9.00 low.
Is XRAY stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 14 analyst ratings, 3 are Buy or Strong Buy, 9 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for XRAY?+
The Street-high target is $17.00 (UBS), and the Street-low is $9.00 (Barclays). The average of all 11 active targets is $13.92.
How many Wall Street analysts cover XRAY?+
14 analysts have an active rating on Dentsply Sirona Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering XRAY?+
Among analysts who currently cover XRAY, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #172). Their current call is Hold with a $14.00 target.
What is Dentsply Sirona Inc's projected EPS for next quarter?+
The consensus estimate is $0.37 per share (range $0.34 – $0.42) across 18 analysts. Full-year EPS is projected at $1.42, rising to $1.55 the following year.
How much revenue is Dentsply Sirona Inc expected to report next quarter?+
Consensus revenue is $874.2M (range $857.7M – $894.8M). Full-year revenue is projected at $3.6B, growing to $3.7B next year.
Have analysts been upgrading or downgrading XRAY lately?+
As of Jul, 3 of 14 firms rate XRAY a Buy (9 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XRAY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
